Farmaceutica REMEDIA S.A. (BVB:RMAH)
Romania · Delayed Price · Currency is RON 0.8000
+0.0040 (0.50%)
At close: Nov 13, 2026
Farmaceutica REMEDIA Ratios and Metrics
Market cap in millions RON. Fiscal year is January - December.
Millions RON. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 75 | 76 | 61 | 64 | 56 | 66 | |
Market Cap Growth | 14.44% | 24.29% | -5.17% | 14.41% | -15.47% | -1.88% |
Enterprise Value | 37 | 21 | 31 | 40 | 27 | 48 |
Last Close Price | 0.80 | 0.75 | 0.59 | 0.57 | 0.46 | 0.51 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 19.13 | 9.42 | 8.75 | 8.92 | 9.67 | 9.19 |
PS Ratio | 0.10 | 0.10 | 0.08 | 0.11 | 0.11 | 0.14 |
PB Ratio | 1.02 | 0.95 | 0.82 | 0.91 | 0.82 | 0.97 |
P/TBV Ratio | 1.04 | 0.97 | 0.84 | 0.92 | 0.83 | 0.99 |
P/FCF Ratio | - | 5.33 | 3.55 | 2.94 | - | 25.61 |
P/OCF Ratio | 88.47 | 4.87 | 3.21 | 2.77 | - | 25.25 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.05 | 0.03 | 0.04 | 0.07 | 0.05 | 0.10 |
EV/EBITDA Ratio | 3.56 | 1.31 | 1.97 | 3.71 | 2.63 | 5.27 |
EV/EBIT Ratio | 4.78 | 1.50 | 2.37 | 5.98 | 4.27 | 5.81 |
EV/FCF Ratio | - | 1.46 | 1.80 | 1.85 | - | 18.54 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.03 | 0.02 | 0.02 |
Debt / EBITDA Ratio | 0.06 | 0.05 | 0.06 | 0.18 | 0.11 | 0.13 |
Debt / FCF Ratio | - | 0.05 | 0.05 | 0.10 | - | 0.52 |
Net Debt / Equity Ratio | -0.52 | -0.72 | -0.63 | -0.46 | -0.25 | -0.33 |
Net Debt / EBITDA Ratio | -3.92 | -3.61 | -2.97 | -2.97 | -1.62 | -2.50 |
Net Debt / FCF Ratio | 44.03 | -4.02 | -2.72 | -1.48 | 8.33 | -8.82 |
Asset Turnover | 3.59 | 2.01 | 2.16 | 1.97 | 2.00 | 1.93 |
Inventory Turnover | 26.77 | 11.95 | 13.89 | 12.33 | 11.52 | 11.84 |
Quick Ratio | 0.91 | 0.90 | 0.91 | 0.94 | 0.91 | 0.92 |
Current Ratio | 1.10 | 1.11 | 1.11 | 1.12 | 1.12 | 1.14 |
Return on Equity (ROE) | 6.23% | 10.47% | 9.62% | 10.34% | 8.50% | 9.77% |
Return on Assets (ROA) | 2.24% | 2.27% | 2.37% | 1.40% | 1.50% | 2.09% |
Return on Invested Capital (ROIC) | 8.57% | 27.53% | 19.71% | 12.14% | 10.93% | 15.13% |
Return on Capital Employed (ROCE) | 9.40% | 16.20% | 16.60% | 8.90% | 9.00% | 11.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.23% | 10.62% | 11.43% | 11.21% | 10.35% | 10.89% |
FCF Yield | -1.15% | 18.77% | 28.19% | 33.99% | -3.61% | 3.91% |
Dividend Yield | 6.25% | 6.19% | 6.21% | 7.18% | 8.48% | 7.16% |
Payout Ratio | 84.03% | 41.68% | 90.34% | 58.18% | 76.95% | 184.63% |
Buyback Yield / Dilution | -7.70% | 0.04% | 0.01% | 0.03% | -0.13% | 10.06% |
Total Shareholder Return | -1.45% | 6.23% | 6.22% | 7.22% | 8.35% | 17.22% |